A pre-emptive strike against malaria's stealthy hepatic forms


Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite. Widespread drug resistance severely restricts our ability to control malaria and makes it necessary to seek novel antimalarial compounds. Here, we advocate the development of true causal chemoprophylactic… (More)
DOI: 10.1038/nrd2960


5 Figures and Tables